Understanding the mechanisms causing lower levels of cortical [3H]pirenzepine binding has been advanced by studies showing lower levels of CHRM1 gene expression (Dean et al., 2002; Mancama et al., 2003) and protein in the DFPLC of people with schizophrenia. The gene discussed is CHRM1; the disease is schizophrenia.